GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (OTCPK:LDXHF) » Definitions » ROIC %

Lumos Diagnostics Holdings (Lumos Diagnostics Holdings) ROIC % : -47.27% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Lumos Diagnostics Holdings's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was -47.27%.

As of today (2024-06-22), Lumos Diagnostics Holdings's WACC % is 11.29%. Lumos Diagnostics Holdings's ROIC % is -38.35% (calculated using TTM income statement data). Lumos Diagnostics Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Lumos Diagnostics Holdings ROIC % Historical Data

The historical data trend for Lumos Diagnostics Holdings's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings ROIC % Chart

Lumos Diagnostics Holdings Annual Data
Trend Jun22 Jun23
ROIC %
-65.42 -33.45

Lumos Diagnostics Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
ROIC % Get a 7-Day Free Trial -42.29 -76.65 -40.54 -29.39 -47.27

Competitive Comparison of Lumos Diagnostics Holdings's ROIC %

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumos Diagnostics Holdings's ROIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's ROIC % distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's ROIC % falls into.



Lumos Diagnostics Holdings ROIC % Calculation

Lumos Diagnostics Holdings's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Jun. 2023 is calculated as:

ROIC % (A: Jun. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jun. 2022 ) + Invested Capital (A: Jun. 2023 ))/ count )
=-9.527 * ( 1 - 0% )/( (32.212 + 24.747)/ 2 )
=-9.527/28.4795
=-33.45 %

where

Lumos Diagnostics Holdings's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-11.26 * ( 1 - 0% )/( (24.747 + 22.895)/ 2 )
=-11.26/23.821
=-47.27 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumos Diagnostics Holdings  (OTCPK:LDXHF) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Lumos Diagnostics Holdings's WACC % is 11.29%. Lumos Diagnostics Holdings's ROIC % is -38.35% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Lumos Diagnostics Holdings ROIC % Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumos Diagnostics Holdings (Lumos Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
2724 Loker Ave West, Carlsbad, CA, USA, 92010
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (Lumos Diagnostics Holdings) Headlines